Cargando…
Durability and cross-reactivity of immune responses induced by a plant-based virus-like particle vaccine for COVID-19
As the SARS-CoV-2 pandemic evolves, vaccine evaluation needs to include consideration of both durability and cross-reactivity. This report expands on previously reported results from a Phase 1 trial of an AS03-adjuvanted, plant-based coronavirus-like particle (CoVLP) displaying the spike (S) glycopr...
Autores principales: | Gobeil, Philipe, Pillet, Stéphane, Boulay, Iohann, Charland, Nathalie, Lorin, Aurélien, Cheng, Matthew P., Vinh, Donald C., Boutet, Philippe, Van Der Most, Robbert, Roman, François, Ceregido, Maria Angeles, Landry, Nathalie, D’Aoust, Marc-André, Ward, Brian J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9653456/ https://www.ncbi.nlm.nih.gov/pubmed/36371408 http://dx.doi.org/10.1038/s41467-022-34728-1 |
Ejemplares similares
-
Safety and immunogenicity of an AS03-adjuvanted plant-based SARS-CoV-2 vaccine in Adults with and without Comorbidities
por: Charland, Nathalie, et al.
Publicado: (2022) -
Phase 1 randomized trial of a plant-derived virus-like particle vaccine for COVID-19
por: Ward, Brian J., et al.
Publicado: (2021) -
Efficacy and Safety of a Recombinant Plant-Based Adjuvanted Covid-19 Vaccine
por: Hager, Karen J., et al.
Publicado: (2022) -
The establishment of surrogates and correlates of protection: Useful tools for the licensure of effective influenza vaccines?
por: Ward, Brian J., et al.
Publicado: (2018) -
Robust induction of functional humoral response by a plant-derived Coronavirus-like particle vaccine candidate for COVID-19
por: Kaplonek, Paulina, et al.
Publicado: (2023)